Propanc Biopharma Inc (PPCB)

[TheHungryHippo]

Propanc Biopharma Inc. is a clinical-stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers. The company's lead product PRP has been designated an Orphan Drug by the FDA. PRP uses cancer stem cell therapy as a major weapon in eradicating tumorous cancers. This revolutionary therapy uses two pancreatic enzymes trypsinogen and chrymotrysinogen to stop cancer stem cells machinery by turning them into normal cells. PRP's approach suppresses metastasis and tumor relapse, which is the main cause of patient death from cancer. PRP complements conventional therapies safe at specified dosage with minimal toxic effects.